Oramed Pharmaceuticals

ORMP • NASDAQ • Stock Fundamentals

Oramed Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Nadav Kidron, with a market cap of $155.5M.

Market Cap$155.5M

Employees15.0

CEONadav Kidron

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 19, 2026 · 26 days agoQ1 2026

Next EarningsAug 13, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Oramed Pharmaceuticals

Oramed Pharmaceuticals (ORMP) has a market capitalization of $155.5M and trades on NASDAQ.

Oramed Pharmaceuticals has approximately 15 employees.